What is the Trade Name for ACLIDINIUM BROMIDE AND FORMOTEROL FUMARTE
DUAKLIR PRESSAIR
What is the Indication for ACLIDINIUM BROMIDE AND FORMOTEROL FUMARTE
1 INDICATIONS AND USAGE DUAKLIR PRESSAIR is a combination of aclidinium bromide (an anticholinergic) and formoterol fumarate (a LABA) indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Limitations of Use : DUAKLIR PRESSAIR is not indicated for the relief of acute bronchospasm or for the treatment of asthma [see Warnings and Precautions (5.1, 5.4) ] . DUAKLIR PRESSAIR is a combination of aclidinium bromide an anticholinergic, and formoterol fumarate, a long-acting beta 2 -adrenergic agonist (LABA) indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). (1) Limitations of Use : Not indicated for the relief of acute bronchospasm or for the treatment of asthma. (1, 5.4).